Drug intelligence / Profile preview

taoren honghua jian

Development stage: Unknown
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Taoren Honghua Jian is a Traditional Chinese Medicine (TCM) herbal formula primarily composed of *Prunus persica* (Peach Kernel) and *Carthamus tinctorius* (Safflower). Developed and studied by Longhua Hospital at the Shanghai University of Traditional Chinese Medicine, it is traditionally used to "activate blood and resolve stasis." In modern clinical research, it is being evaluated for its ability to modulate immune function and improve outcomes in patients with stable coronary artery disease. The formula is typically prepared as an oral decoction and is investigated for its anti-inflammatory and microcirculation-enhancing properties.

Other names: Peach Kernel and Safflower DecoctionTaoren Honghua Decoction

Targets

GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on taoren honghua jian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on taoren honghua jian.

Explore the full profile